Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,488 | 7 | 93.0% |
| Food and Beverage | $1,090 | 16 | 5.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $289.00 | 1 | 1.4% |
| Travel and Lodging | $90.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $16,168 | 16 | $0 (2017) |
| Pharmacyclics LLC, An AbbVie Company | $2,669 | 3 | $0 (2017) |
| Gilead Sciences Inc | $1,500 | 1 | $0 (2017) |
| F. Hoffmann-La Roche AG | $289.00 | 1 | $0 (2017) |
| Genentech USA, Inc. | $137.88 | 2 | $0 (2017) |
| Kite Pharma, Inc. | $124.99 | 1 | $0 (2018) |
| Celgene Corporation | $66.97 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $124.99 | 1 | Kite Pharma, Inc. ($124.99) |
| 2017 | $20,831 | 24 | AbbVie, Inc. ($16,168) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2018 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONC | ||||||
| 09/30/2017 | F. Hoffmann-La Roche AG | VENCLEXTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $289.00 | General |
| Category: BioOncology | ||||||
| 08/14/2017 | AbbVie, Inc. | Venclexta (Drug) | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| Category: Virology | ||||||
| 08/09/2017 | AbbVie, Inc. | Venclexta (Drug) | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| Category: Virology | ||||||
| 06/16/2017 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $98.31 | General |
| Category: BioOncology | ||||||
| 06/12/2017 | AbbVie, Inc. | Venclexta (Drug) | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| Category: Virology | ||||||
| 06/12/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Oncology | ||||||
| 06/01/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: Virology | ||||||
| 05/31/2017 | Gilead Sciences Inc | Zydelig (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: ONC | ||||||
| 05/13/2017 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA | Food and Beverage | In-kind items and services | $39.57 | General |
| Category: BioOncology | ||||||
| 05/12/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $106.33 | General |
| Category: Virology | ||||||
| 05/12/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $59.40 | General |
| Category: Virology | ||||||
| 05/11/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $116.19 | General |
| Category: Oncology | ||||||
| 05/11/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $91.28 | General |
| Category: Virology | ||||||
| 05/11/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $53.04 | General |
| Category: Oncology | ||||||
| 05/11/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Virology | ||||||
| 05/11/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Virology | ||||||
| 04/28/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $91.27 | General |
| Category: Virology | ||||||
| 04/18/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $66.97 | General |
| 04/12/2017 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,612.50 | General |
| 03/23/2017 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $90.00 | General |
| 03/23/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $36.57 | General |
| Category: Virology | ||||||
| 03/21/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $67.16 | General |
| Category: Virology | ||||||
| 01/19/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $63.71 | General |
| Category: Virology | ||||||
| 01/10/2017 | AbbVie, Inc. | Venclexta (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Virology | ||||||
About Dr. Jeffrey Jones, M.D
Dr. Jeffrey Jones, M.D is a Hematology & Oncology healthcare provider based in Cambridge, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720098056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Jones, M.D has received a total of $20,956 in payments from pharmaceutical and medical device companies, with $124.99 received in 2018. These payments were reported across 25 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($19,488).
Practice Information
- Specialty Hematology & Oncology
- Location Cambridge, MA
- Active Since 08/09/2006
- Last Updated 12/30/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720098056
Products in Payments
- Venclexta (Drug) $8,466
- Imbruvica (Drug) $2,669
- Zydelig (Drug) $1,500
- VENCLEXTA (Biological) $289.00
- GAZYVA (Biological) $137.88
- Yescarta (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cambridge
Robert Fram, M.d, M.D
Hematology & Oncology — Payments: $159,285
Iris Sheng, M.d, M.D
Hematology & Oncology — Payments: $847.19
Debashish Misra, M.d, M.D
Hematology & Oncology — Payments: $456.08
Dr. Thomas Caughey, Md, MD
Hematology & Oncology — Payments: $420.08
Dr. Nabiel Alkhouri, M.d, M.D
Hematology & Oncology — Payments: $377.33
Anna Berkenblit, M.d, M.D
Hematology & Oncology — Payments: $67.56